National award for consultant cardiologist

William Bradlow, consultant cardiologist at BHP founding member University Hospitals Birmingham NHS Foundation Trust, recently won Cardiomyopathy UK’s Ronald Raven Award for Clinical Excellence. William won a prestigious public vote, with patients and Cardiomyopathy UK staff and volunteers nominating the healthcare professional who had made the biggest difference to cardiomyopathy patients across the country. “I’m delighted to have won the Clinical Excellence Award, and would like to thank everyone who voted for me,” said William. … Continue reading “National award for consultant cardiologist”

Study confirms most effective treatment for HPV-positive throat cancer

Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with radiotherapy, according to research led by BHP founder member the University of Birmingham. An abstract of the Cancer Research UK-funded study, which was carried out in collaboration with the University of Warwick, was recently delivered at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany. The trial aimed to compare, for the first time, the outcomes of using two … Continue reading “Study confirms most effective treatment for HPV-positive throat cancer”

New research will study smallest vessels of the heart

New research by founding member the University of Birmingham, funded by the British Heart Foundation (BHF), will study the damage caused to the smallest vessels of the heart following a heart attack. Researchers at the University have developed a state-of-the-art imaging technique, which was funded by a previous BHF grant. This particular microscopy technique allows them to look in detail at microvessels in the beating heart. Microvessels are so small that they cannot be seen … Continue reading “New research will study smallest vessels of the heart”

Team effort keeps blood trial on track

BHP-led RePHILL (REsuscitation with Pre-HospItaL bLood products) is the UK’s first trial in which eligible patients are recruited by ‘pre-hospital emergency medical (PHEM) teams’ and are randomly allocated treatment with either pre-hospital blood products or the standard care, saline. The RePHILL trial assesses the effects of giving trauma patients blood products after a major injury, but before reaching hospital, and thanks to regional collaboration, has now recruited over 100 patients. Alongside the work taking place … Continue reading “Team effort keeps blood trial on track”

New guidelines aim to improve diagnosis and treatment for condition that can leave young women blind

Clinicians from founding member University Hospitals Birmingham NHS Foundation Trust (UHB) have led the production of the world’s first treatment guidelines for a rare condition that can leave young women blind and suffering daily painful headaches. Idiopathic Intracranial Hypertension (IIH) mainly affects obese women in their 20s and 30s and incidences are on the rise, in line with the global rise in obesity numbers. Those with the condition generally have a BMI of over 30 … Continue reading “New guidelines aim to improve diagnosis and treatment for condition that can leave young women blind”